Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Yamamoto, K.
Right arrow Articles by Bando, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, K.
Right arrow Articles by Bando, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
Hazardous Substances DB
*MAGNESIUM COMPOUNDS
*MAGNESIUM SULFATE
*VERAPAMIL HYDROCHLORIDE
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Effects of Verapamil and Magnesium Sulfate on Electrophysiologic Changes During Acute Myocardial Ischemia and Following Reperfusion in Dogs: Comparative Effects of Administration by Intravenous and Coronary Sinus Retroperfusion Routes

Katsuhito Yamamoto

Second Department of Internal Medicine, School of Medicine, The University of Tokushima, Tokushima, Japan

Shigenobu Bando

Second Department of Internal Medicine, School of Medicine, The University of Tokushima, Tokushima, Japan

The authors evaluated the effects of verapamil (Ve) and magnesium sulfate (Mg) on the electrophysiologic changes induced in dogs during acute myocardial ischemia and following reperfusion. The effects of their intravenous (IV) administration and adminis tration by coronary sinus retroperfusion (CSR) were also compared. Sixty-five dogs were divided into five groups : Ve-IV: 9 dogs, 0.1 mg/kg; Ve-CS: 9 dogs, 0.05 mg/kg; Mg-IV: 12 dogs, 20 mg/kg; Mg-CS: 11 dogs, 10 mg/kg, control: 24 dogs. The left anterior descending coronary artery was ligated for ten minutes, then quickly reopened. The changes in ventricular effective refractory period (ERP) and intramyocardial conduction time (ICT) were determined during ischemia and following reperfusion.

The authors observed a shortening of the ERP and a prolongation of the ICT in the control group versus an attenuation of those effects in all other groups. The ERP was shortened to a lesser extent in the Mg-IV group than in the Ve-IV group. Drug adminis tration by CSR inhibited the changes in ERP and ICT to a greater extent than IV admin istration, even though the dose given by CSR was one-half the IV dose. Ventricular fibril lation (Vf) occurred in 12 of 24 dogs (50%) in the control group during ischemia, and in 5 of 12 dogs (41.7%) following reperfusion. Vf occurred during ischemia and following reperfusion, respectively, in 22.2% and 0% in the Ve-IV and Ve-CS groups, in 25% and 22.2% in the Mg-IV group, and in 9.1% and 10% in the Mg-CS group. Thus, verapamil and magnesium sulfate inhibited the electrophysiologic changes and prevented ventric ular arrhythmias during myocardial ischemia and following reperfusion.

Administering the antiarrhythmic agent by coronary sinus retroperfusion may be useful for treating patients with acute myocardial infarction with intractable arrhyth mias, according to these experimental results.

Angiology, Vol. 47, No. 6, 557-568 (1996)
DOI: 10.1177/000331979604700604


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement